How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

32,043 results for

Hypertension Evaluation History

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Does Family History of Obesity, Cardiovascular, and Metabolic Diseases Influence Onset and Severity of Childhood Obesity? (PubMed)

Does Family History of Obesity, Cardiovascular, and Metabolic Diseases Influence Onset and Severity of Childhood Obesity? The objectives were to evaluate (1) the metabolic profile and cardiometabolic risk in overweight/obese children at first assessment, stratifying patients according to severity of overweight and age; and (2) to investigate the relationship between family history (FH) for obesity and cardiometabolic diseases and severity of childhood obesity.In this cross-sectional (...) ), mostly prepubertal, presented a significantly higher HOMA-IR (p = 0.04), and had a significantly higher prevalence of FH for arterial hypertension, type 2 diabetes mellitus, and coronary heart disease than the other group.(1) Family history of obesity and cardiometabolic diseases are important risk factors for precocious obesity onset in childhood and are related to the severity of obesity. (2) Metabolic profile, especially HOMA-IR, is altered even among the youngest obese children at first

Full Text available with Trip Pro

2018 Frontiers in endocrinology

82. MKSAP: 82-year-old woman with a 1-week history of urinary incontinence

MKSAP: 82-year-old woman with a 1-week history of urinary incontinence Treatment is indicated in all patients with symptomatic cystitis MKSAP: 82-year-old woman with a 1-week history of urinary incontinence | | November 24, 2018 0 Shares Test your medicine knowledge with the , in partnership with the . An 82-year-old woman is evaluated for a 1-week history of urinary incontinence with lower abdominal discomfort. She reports no dysuria, fever, or back pain. Medical history is significant (...) for hypertension and allergic reaction to sulfa drugs, which cause a generalized rash. Her only medication is amlodipine. On physical examination, temperature is 36.8 °C (98.2 °F), blood pressure is 150/90 mm Hg, pulse rate is 72/min, and respiration rate is 16/min. Mild suprapubic tenderness but no costovertebral angle tenderness are noted on abdominal examination. The remainder of the examination is noncontributory. Urine dipstick is positive for leukocyte esterase and nitrites. Which of the following

2018 KevinMD blog

83. Pharmacodynamics, Safety and Pharmacokinetics of the Oral Administration MNK6106 (L-ornithine Phenylacetate) vs Rifaximin in Participants With Hepatic Cirrhosis and a History of Prior Episodes of Hepatic Encephalopathy

Party): Mallinckrodt Study Details Study Description Go to Brief Summary: The primary objectives of this study are to evaluate the pharmacological activities through plasma ammonia (AMM) concentration as a pharmacodynamic (PD) marker following oral administrations of MNK6106 with rifaximin as a control in participants with hepatic cirrhosis and a history of prior episodes of Hepatic encephalopathy (HE). Condition or disease Intervention/treatment Phase Hepatic Cirrhosis Hepatic Encephalopathy Drug (...) ammonia (AMM) from baseline. [ Time Frame: Baseline to 5 days ] To evaluate the pharmacological activities through plasma AMM concentration as a PD marker following oral administrations of MNK6106 with rifaximin as a control in subjects with hepatic cirrhosis and a history of prior episodes of HE. Secondary Outcome Measures : Percentage of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs) [ Time Frame: Baseline up to Final Visit (7 days postdosing) (+ 3 day

2018 Clinical Trials

84. Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia (PubMed)

Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia To evaluate long-term IPSS score and urinary quality of life after radiotherapy for prostate cancer, in patients with prior history of surgical treatment for benign prostatic hyperplasia (BPH).In this retrospective study, we reviewed medical records of patients treated in our department, between 2007 and 2013 with surgery for BPH (...) were urinary symptoms (65%) and urinary retention (20%). Five-year biochemical-disease free survival was 75% and 5-year clinical relapse free survival was 84%. At the time of the study, the IPSS after radiotherapy was as follows: 0-7: 77.6%; 8-19:20.7%; 20-35: 1.7%. Urinary quality of life was satisfactory for 74.2% of patients. After multivariate analysis, a high dose of RT and a medical history of hypertension were associated with a poorer quality of urinary life (p = 0.04).External radiotherapy

Full Text available with Trip Pro

2018 Radiation oncology (London, England)

85. Diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion

@asrm.org). Fertility and Sterility® Vol. 110, No. 5, October 2018 0015-0282/$36.00 Copyright ©2018 American Society for Reproductive Medicine, Published by Elsevier Inc. https://doi.org/10.1016/j.fertnstert.2018.07.010 VOL. 110 NO. 5 / OCTOBER 2018 833 ASRM PAGESA comprehensive history and physical examination with focus on risk factors for cardiovascular disease are critical parts of the ED evaluation. Speci?cally, the man should be queried about whether he has had regular primary care; any (...) comorbidconditionssuchasdiabetes,hypertension,coronary artery disease, or other cardiac conditions; history of penile, prostate, or spine surgery; social history with an emphasis on smoking or other recreational drugs; or family history of cardiovascular disease.Medicationusesuchasbetablockers, hydrochlorothiazide, other antihypertensives, exogenous testosterone use, use of phosphodiesterase type-5 inhibitors (PDE5i) (such as sildena?l, tadala?l, avana?l, or vardena?l), or use of penile injection therapy should also

2018 Society for Assisted Reproductive Technology

86. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

%/y. Pulmonary Hypertension The evaluation of a patient with RVD includes an assessment for increased RV afterload. PH is characterized by alterations in the pulmonary vasculature leading to increased PVR and ultimately RVD. The increased afterload on the RV leads to RV hypertrophy, dilation, and systolic dysfunction. PH is defined as a mean PAP ≥25 mm Hg and when present is associated with impaired survival. PH is found in isolation and as a consequence of other diseases as detailed below (...) Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January

Full Text available with Trip Pro

2018 American Heart Association

87. Evaluation and Management of Right-Sided Heart Failure

fibrosis in 99% of patients with repaired TOF and LV fibrosis in 53%. In 10% to 15% of patients, pulmonary insufficiency leads to progressive RV dilatation and dysfunction and may require PV replacement later in life. , Left unrepaired, RV dilatation and dysfunction can lead to ventricular arrhythmias with a rate of SCD in this population estimated to be 0.3%/y. Pulmonary Hypertension The evaluation of a patient with RVD includes an assessment for increased RV afterload. PH is characterized (...) Evaluation and Management of Right-Sided Heart Failure Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 Free Access article Share on Jump to Free Access article

Full Text available with Trip Pro

2018 International Society for Heart and Lung Transplantation

88. Evaluation and Management of Testosterone Deficiency

Evaluation and Management of Testosterone Deficiency 1 Executive Summary Testosterone testing and prescriptions have nearly tripled in recent years; however, it is clear from clinical practice that there are many men using testosterone without a clear indication. 1-3 Some studies estimate that up to 25% of men who receive testosterone therapy do not have their testosterone tested prior to initiation of treatment. 2, 3 Of men who are treated with testosterone, nearly half do not have (...) of interest and author/staff contribu- tions appear at the end of the article. © 2018 by the American Urological Association American Urological Association (AUA) EVALUATION AND MANAGEMENT OF TESTOSTERONE DEFICIENCY: AUA GUIDELINE John P. Mulhall, MD; Landon W. Trost, MD; Robert E. Brannigan, MD; Emily G. Kurtz, MD; J. Bruce Redmon, MD; Kelly A. Chiles, MD MSc; Deborah J. Lightner, MD; Martin M. Miner, MD; M. Hassan Murad, MD, MPH; Christian J. Nelson, PhD; Elizabeth A. Platz, ScD, MPH; Lakshmi V

2018 American Urological Association

89. Guidelines for the Economic Evaluation of Health Technologies in Ireland

Guidelines for the Economic Evaluation of Health Technologies in Ireland 1 Guidelines for the Economic Evaluation of Health Technologies in Ireland 2018 Guidelines for the Economic Evaluation of Health Technologies in Ireland Health Information and Quality Authority Guidelines for the Economic Evaluation of Health Technologies in Ireland Health Information and Quality Authority 3 About the Health Information and Quality Authority The Health Information and Quality Authority (HIQA (...) . ? Monitoring Healthcare Safety and Quality – Monitoring the safety and quality of health services and investigating as necessary serious concerns about the health and welfare of people who use these services. ? Health Technology Assessment – Providing advice that enables the best outcome for people who use our health service and the best use of resources by evaluating the clinical effectiveness and cost-effectiveness of drugs, equipment, diagnostic techniques and health promotion and protection activities

2018 Health Information and Quality Authority

90. Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy

Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy Compare the predictive performance of Framingham Risk Score (FRS), Pooled Cohort Equations (PCEs) and Systematic COronary Risk Evaluation (SCORE) model between women with and without a history of hypertensive disorders of pregnancy (hHDP) and determine the effects of recalibration and refitting on predictive performance.We included 29 751 women, 6302 with hHDP and 17 369 without. We assessed

2018 EvidenceUpdates

91. Hypertension - Diagnosis and Management

: AOBP = automatic office blood pressure; ABPM = ambulatory blood pressure monitoring; BP = blood pressure; CVD = cardiovascular disease; DBP = diastolic blood pressure; Dx = diagnosis; HBPM = home blood pressure monitoring; HTN = hypertension; MOBP = manual office blood pressure. Footnote: a Out-of-office method may include automated BP machines at pharmacies or grocery stores. b Sign/symptoms may include papilloedema and retinal hemorrhage. Investigations and work-up includes: • Medical history (...) to BCGuidelines.ca – Chronic Kidney Disease – Identification, Evaluation and Management of Adult Patients. Initial Investigations: • eGFR • Urinalysis - albumin to creatinine ratio (ACR), hematuria • Physical exam & medical history • Renal ultrasound Cushing’s Syndrome Signs/symptoms: • Cushingoid facies • Central obesity • Proximal muscle weakness • Ecchymoses Initial Investigations may include any of: • late-night salivary cortisol levels • 24-hour urine free cortisol (UFC) • low-dose (1-mg overnight or 48

2015 Clinical Practice Guidelines and Protocols in British Columbia

92. Predictive Value of Mean Platelet Volume in Variceal Bleeding due to Cirrhotic Portal Hypertension (PubMed)

Predictive Value of Mean Platelet Volume in Variceal Bleeding due to Cirrhotic Portal Hypertension To investigate whether mean platelet volume (MPV) is a predictor of variceal bleeding in patients with cirrhotic portal hypertension.This prospective cohort was performed in the internal medicine department of our tertiary care center. Cirrhotic patients were allocated into two groups: Group I consisted of 31 cases without a history of variceal bleeding, whereas group II was made up of 31 patients (...) with a history of variceal bleeding. Data derived from medical history, physical examination, ultrasonography, gastrointestinal system endoscopy, complete blood count, hepatic, and renal function tests were recorded and compared between two groups. On physical examination, encephalopathy and ascites were evaluated and graded with respect to Child-Pugh-Turcotte classification.There was no significant difference between the two groups in terms of age, duration of the disease, and gender of the patient

Full Text available with Trip Pro

2017 Euroasian journal of hepato-gastroenterology

93. Hypertension - Diagnosis and Management

to investigations and work-up to assess target organ damage and cardiovascular disease (CVD) risk. Select which arm to use by measuring BP in both arms with the patient in a seated position. Measure BP three more times using the arm with the higher reading, then discard the 1 st reading and average the latter two. Figure 1. Diagnosis of hypertension algorithm Investigations and work-up includes: Medical history - ask about risk factors and rule out any exogenous factors Risk Factors Modifiable: smoking (...) ; 57(4):689–94. Roush GC, Holford TR, Guddati AK. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: Systematic review and network meta-analyses. Hypertension. 2012;59(6):1110–17. Messerli FH, Makani H, Benjo A, et al. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: A meta-analysis of randomized trials. JACC. 2011;57(5):590-300. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group

2015 Clinical Practice Guidelines and Protocols in British Columbia

94. Evaluating Sistema Scotland: evaluation plan

Evaluating Sistema Scotland: evaluation plan Evaluating Sistema Scotland Evaluation plan: Sistema Scotland’s Big Noise programmes in Raploch, Stirling and in Govanhill, Glasgow Chris Harkins Senior Public Health Research Specialist June 2014 Picture credit: Marc Marnie. Chris Harkins Senior Public Health Research Specialist Glasgow Centre for Population Health 1st Floor, House 6 94 Elmbank Street Glasgow G2 4NE UK Email: Chris.Harkins@drs.glasgow.gov.uk This plan should be cited as: Harkins C (...) . Evaluating Sistema Scotland. Glasgow: GCPH; 2014. 2 Contents Executive summary 4 Introduction 8 Sistema Scotland 8 The Glasgow Centre for Population Health 9 Overview of important contextual evidence 10 The shared challenge of Scotland’s health inequalities 10 The socio-behavioural determinants of modern disease 11 The pivotal importance of the early years 12 ‘Measurement’ of the arts 13 The arts, cultural participation, health and wellbeing 14 ‘Arts and smarts’ – the impact of the arts on educational

2014 Glasgow Centre for Population Health

95. Hypertensive Urgency: Considerations for Management

on the floor & arm supported) (Please refer to Hypertension Canada’s Blood Pressure Measurement Information Sheet for more detailed guidance). ? Obtain medical history & current medication list (prescription, OTC, recreational) ? Physical exam - focus on any signs of target organ damage (e.g. shortness of breath, chest pain, numbness/weakness) ? Lab tests & investigations may be required (e.g. CBC, ECG, urinalysis, renal function; ultrasound for aortic dissection if very high BP) ? Hypertensive urgency (...) , Calcium Channel Blocker Chronic Kidney Disease ACE Inhibitor (or ARB) WHAT ARE THE FOLLOW-UP & MONITORING PARAMETERS FOR HYPERTENSIVE URGENCY? 2-11 ? The patient should be observed for a few hours to confirm that they are stable/improving & asymptomatic ? Once stable, the patient can be sent home with close follow-up (every 1-2 days) involving: - Evaluation for signs of hypertension or hypotension - Attainment of BP goals with the help of antihypertensives and lifestyle interventions (e.g. low salt

2014 RxFiles

96. Whom should you test for secondary causes of hypertension?

that all children and adolescents with a new diagnosis of hypertension undergo renal ultrasound and laboratory evaluation for renal pathology (strength of recommendation [SOR]: C, consensus-based guidelines). Specific diagnostic tests are recommended for newly diagnosed patients who have suspicious clinical findings suggestive of a secondary cause of hypertension based on the initial history (excess daytime sleepiness, palpitations, tremor, sweating); physical examination (abdominal bruit, thyromegaly (...) , malar rash); or laboratory analysis (elevated serum creatinine, low thyroid-stimulating hormone) (SOR: C, consensus-based guidelines). Patients with undifferentiated resistant hypertension should receive further directed evaluation for secondary causes (SOR: C, consensus-based guidelines). URI Citation Journal of Family Practice, 63(1) 2014: 41-42, 54. Rights OpenAccess. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. Collections hosted by hosted by

2014 Clinical Inquiries

97. Economic Evaluation of Unfractionated Heparin Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in General Medical and Non Orthopedic Surgical Patients

Economic Evaluation of Unfractionated Heparin Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in General Medical and Non Orthopedic Surgical Patients Economic Evaluation of Unfractionated Heparin Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in General Medical and Non Orthopedic Surgical Patients | CADTH.ca CADTH Document Viewer Economic Evaluation of Unfractionated Heparin Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism (...) in General Medical and Non Orthopedic Surgical Patients Table of Contents Search this document Economic Evaluation of Unfractionated Heparin Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in General Medical and Non Orthopedic Surgical Patients April 2017 Key Finding: Economic Evaluation The price of low-molecular-weight heparin (LMWH) has decreased since it was marketed in the mid‑1990s in Canada, while unfractionated heparin (UFH) has recently become more costly because of changes

2017 CADTH - Plasma Products

98. American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis

with compensated cirrhosis with known esophageal varices or portal hypertension, were not considered in this analysis and, therefore, endoscopic evaluation should be pursued in these patients as per standard clinical practice without consideration of a VCTE cutoff of 19.5 kPa. Guidelines of the Baveno VI Consensus Workshop further support risk stratification based on a VCTE cutoff of <20 kPa and platelet count >150,000/μL. x 19 de Franchis, R. and Baveno VI Faculty. Expanding consensus in portal hypertension (...) esophageal varices), potentially minimizing the need for routine invasive testing for portal hypertension (endoscopy, hepatic venous pressure gradient measurement)? In this context, VCTE was evaluated as an add-on triage test to better define which patients may benefit from further investigation of clinically significant portal hypertension. The diagnostic performance of a prespecified cutoff of 17.0 (±2) kPa to rule out clinically significant portal hypertension was interpreted in 3 illustrative

2017 American Gastroenterological Association Institute

99. American Gastroenterological Association Institute guideline on the role of elastography in the evaluation of liver fibrosis.

, further testing (with upper endoscopy or hepatic venous pressure gradient) to evaluate clinically significant portal hypertension may be warranted before a patient is deemed high risk for elective surgery. Total articles identified: 4577 Total studies included: 79 Weighting According to a Rating Scheme (Scheme Given) Grading of Recommendations Assessment, Development and Evaluation (GRADE) Definitions of Quality/Certainty of the Evidence High The Committee is very confident that the true effect lies (...) , prospective evaluation of the utility of VCTE as a triage test to evaluate for absence of high-risk esophageal varices (EVs) and ruling our clinically significant portal hypertension before elective surgery is warranted. Finally, although a variety of noninvasive imaging-based fibrosis assessment modalities have been developed, the committee's review focused on VCTE and magnetic resonance elastography (MRE) only; a detailed synthesis of the performance and utility of other noninvasive imaging modalities

2017 National Guideline Clearinghouse (partial archive)

100. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

2. General Principles e30 2.1. Definitions: Terms and Classification e30 2.2. Epidemiology and Demographics e31 2.3. Initial Evaluation of Patients with Syncope: Recommendations e31 2.3.1. History and Physical Examination: Recommendation e31 2.3.2. Electrocardiography: Recommendation e31 2.3.3. Risk Assessment: Recommendations e32 2.3.4. Disposition After Initial Evaluation: Recommendations e32 3. Additional Evaluation and Diagnosis e33 3.1. Blood Testing: Recommendations e33 3.2. Cardiovascular (...) vision” or “graying out”; and variable degrees of altered consciousness without complete loss of consciousness. Presyncope could progress to syncope, or it could abort without syncope. Unexplained syncope (syncope of undetermined etiology) Syncope for which a cause is undetermined after an initial evaluation that is deemed appropriate by the experienced healthcare provider. The initial evaluation includes but is not limited to a thorough history, physical examination, and ECG. Orthostatic intolerance

2017 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>